Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Dexmedetomidine as an add-on to bupivacaine for a nerve block around the shoulder

Official title: The Analgesic Efficacy of Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-guided Pericapsular Nerve Group Block( PENG) in Patients Undergoing Laparoscopic Shoulder Surgeries: A Randomized Controlled Trial

Run by Kasr El Aini Hospital · NCT07626346 · Data updated 2026-11-12

This trial tests whether adding dexmedetomidine to bupivacaine for a PENG nerve block improves pain control after shoulder surgery in adults.

More Shoulder Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment84 (estimated)
SponsorKasr El Aini Hospital
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJune 10, 2026
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedJune 12, 2026
Trial IDNCT07626346 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 undergoing laparoscopic shoulder procedures (arthroplasty or shoulder endoscopy) with ASA I-II status.

Probably not a fit

Patients with contraindications to dexmedetomidine or those not experiencing improved pain control may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients undergoing elective laparoscopic shoulder procedures are randomized to receive a PENG block with bupivacaine alone or with dexmedetomidine as an adjuvant. The blocks are ultrasound-guided and performed with a standardized technique, and postoperative pain is assessed using a visual analogue scale. All participants receive standard perioperative care and outcome measures include pain ratings and opioid use within the first postoperative period. The study aims to determine if the adjuvant reduces pain and opioid needs without introducing unacceptable risks. Enrollment is limited to adults 18-65 with ASA I-II status undergoing shoulder procedures at Kasr Alainy Hospital in Cairo.

Why it matters

Potential benefit: If successful, patients may experience better early postoperative pain relief and reduced need for opioids after shoulder surgery.

How similar studies have gone: Previous nerve block strategies show benefit for shoulder surgery; this exact dexmedetomidine add-on approach is being tested for potential incremental improvement.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female patients aged 18-65 years
2. Patients Undergoing laparoscopic shoulder surgeries (shoulder arthroplasties and shoulder endoscopic surgeries )
3. American Society of Anesthesiologists (ASA) physical status I-II

Exclusion Criteria:

1. Patient refusal.
2. hypersensitivity or contraindication to dexmedetomidine
3. History of allergy or intolerance to study medications
4. Chronic opioid use (\>3 months)
5. Pregnancy or breastfeeding
6. Severe renal or hepatic impairment
7. Patient's with coagulopathy disorders

Where it's running

  • Kasr Alainy
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.